Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors.

Mazzaferro V, Sposito C, Coppa J, Miceli R, Bhoori S, Bongini M, Camerini T, Milione M, Regalia E, Spreafico C, Gangeri L, Buzzoni R, de Braud FG, De Feo T, Mariani L.

Am J Transplant. 2016 Oct;16(10):2892-2902. doi: 10.1111/ajt.13831. Epub 2016 Jun 9.

2.

Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma.

Facciorusso A, Mariani L, Sposito C, Spreafico C, Bongini M, Morosi C, Cascella T, Marchianò A, Camerini T, Bhoori S, Brunero F, Barone M, Mazzaferro V.

J Gastroenterol Hepatol. 2016 Mar;31(3):645-53. doi: 10.1111/jgh.13147.

PMID:
26331807
3.

Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.

Chiesa C, Mira M, Maccauro M, Spreafico C, Romito R, Morosi C, Camerini T, Carrara M, Pellizzari S, Negri A, Aliberti G, Sposito C, Bhoori S, Facciorusso A, Civelli E, Lanocita R, Padovano B, Migliorisi M, De Nile MC, Seregni E, Marchianò A, Crippa F, Mazzaferro V.

Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1718-1738. doi: 10.1007/s00259-015-3068-8. Epub 2015 Jun 27.

PMID:
26112387
4.

Prediction of survival in patients with thin melanoma: results from a multi-institution study.

Maurichi A, Miceli R, Camerini T, Mariani L, Patuzzo R, Ruggeri R, Gallino G, Tolomio E, Tragni G, Valeri B, Anichini A, Mortarini R, Moglia D, Pellacani G, Bassoli S, Longo C, Quaglino P, Pimpinelli N, Borgognoni L, Bergamaschi D, Harwood C, Zoras O, Santinami M.

J Clin Oncol. 2014 Aug 10;32(23):2479-85. doi: 10.1200/JCO.2013.54.2340. Epub 2014 Jul 7.

5.

Accuracy and prognostic value of sentinel lymph node biopsy in head and neck melanomas.

Patuzzo R, Maurichi A, Camerini T, Gallino G, Ruggeri R, Baffa G, Mattavelli I, Tinti MC, Crippa F, Moglia D, Tolomio E, Maccauro M, Santinami M.

J Surg Res. 2014 Apr;187(2):518-24. doi: 10.1016/j.jss.2013.10.037. Epub 2013 Oct 23.

PMID:
24252855
6.

A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass microspheres.

Chiesa C, Mira M, Maccauro M, Romito R, Spreafico C, Sposito C, Bhoori S, Morosi C, Pellizzari S, Negri A, Civelli E, Lanocita R, Camerini T, Bampo C, Carrara M, Seregni E, Marchianò A, Mazzaferro V, Bombardieri E.

Q J Nucl Med Mol Imaging. 2012 Dec;56(6):503-8.

7.

Where on earth to publish? A sample survey comparing traditional and open access publishing in the oncological field.

Poltronieri E, Bravo E, Camerini T, Ferri M, Rizzo R, Solimini R, Cognetti G.

J Exp Clin Cancer Res. 2013 Jan 22;32:4. doi: 10.1186/1756-9966-32-4.

8.

The use of polytetrafluoroethylene to facilitate the vascular access in recurrent melanoma to limbs.

Ruggeri R, Camerini T, Patuzzo R, Maurichi A, Pirovano R, Mattavelli I, Crippa F, Tolomio E, Moglia D, Di Florio A, Santinami M.

Int J Surg Case Rep. 2013;4(1):40-3. doi: 10.1016/j.ijscr.2012.08.013. Epub 2012 Sep 27.

9.

Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study.

Mazzaferro V, Sposito C, Bhoori S, Romito R, Chiesa C, Morosi C, Maccauro M, Marchianò A, Bongini M, Lanocita R, Civelli E, Bombardieri E, Camerini T, Spreafico C.

Hepatology. 2013 May;57(5):1826-37. doi: 10.1002/hep.26014. Epub 2013 Mar 22.

PMID:
22911442
10.

miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.

Reid JF, Sokolova V, Zoni E, Lampis A, Pizzamiglio S, Bertan C, Zanutto S, Perrone F, Camerini T, Gallino G, Verderio P, Leo E, Pilotti S, Gariboldi M, Pierotti MA.

Mol Cancer Res. 2012 Apr;10(4):504-15. doi: 10.1158/1541-7786.MCR-11-0342. Epub 2012 Feb 16.

11.

Need, feasibility and convenience of dosimetric treatment planning in liver selective internal radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of Milan.

Chiesa C, Maccauro M, Romito R, Spreafico C, Pellizzari S, Negri A, Sposito C, Morosi C, Civelli E, Lanocita R, Camerini T, Bampo C, Bhoori S, Seregni E, Marchianò A, Mazzaferro V, Bombardieri E.

Q J Nucl Med Mol Imaging. 2011 Apr;55(2):168-97. Review.

PMID:
21386789
12.

Methylation status in patients with early stage colon cancer: a new prognostic marker?

Zanutto S, Pizzamiglio S, Lampis A, Camerini T, Di Mauro MG, Pierotti MA, Verderio P, Gariboldi M.

Int J Cancer. 2012 Jan 15;130(2):488-9. doi: 10.1002/ijc.26011. Epub 2011 Apr 25. No abstract available.

13.

Pure desmoplastic melanoma: a melanoma with distinctive clinical behavior.

Maurichi A, Miceli R, Camerini T, Contiero P, Patuzzo R, Tragni G, Crippa F, Romanidis K, Ruggeri R, Carbone A, Santinami M.

Ann Surg. 2010 Dec;252(6):1052-7. doi: 10.1097/SLA.0b013e3181efc23c.

PMID:
21107116
14.

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.

Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabrò E, Pastorino U, Sozzi G.

Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16281-6. doi: 10.1073/pnas.0905653106. Epub 2009 Sep 10.

15.

Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening.

Marchianò A, Calabrò E, Civelli E, Di Tolla G, Frigerio LF, Morosi C, Tafaro F, Ferri E, Sverzellati N, Camerini T, Mariani L, Lo Vullo S, Pastorino U.

Radiology. 2009 Jun;251(3):919-25. doi: 10.1148/radiol.2513081313. Epub 2009 Apr 20.

PMID:
19380692
16.

Plasma retinol and prognosis of postmenopausal breast cancer patients.

Formelli F, Meneghini E, Cavadini E, Camerini T, Di Mauro MG, De Palo G, Veronesi U, Berrino F, Micheli A.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):42-8. doi: 10.1158/1055-9965.EPI-08-0496.

17.

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis.

Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P; Metroticket Investigator Study Group.

Lancet Oncol. 2009 Jan;10(1):35-43. doi: 10.1016/S1470-2045(08)70284-5. Epub 2008 Dec 4.

PMID:
19058754
18.

Biology, prognosis and response to therapy of breast carcinomas according to HER2 score.

Ménard S, Balsari A, Tagliabue E, Camerini T, Casalini P, Bufalino R, Castiglioni F, Carcangiu ML, Gloghini A, Scalone S, Querzoli P, Lunardi M, Molino A, Mandarà M, Mottolese M, Marandino F, Venturini M, Bighin C, Cancello G, Montagna E, Perrone F, De Matteis A, Sapino A, Donadio M, Battelli N, Santinelli A, Pavesi L, Lanza A, Zito FA, Labriola A, Aiello RA, Caruso M, Zanconati F, Mustacchi G, Barbareschi M, Frisinghelli M, Russo R, Carrillo G; OMERO Group.

Ann Oncol. 2008 Oct;19(10):1706-12. doi: 10.1093/annonc/mdn369. Epub 2008 Jun 9.

PMID:
18544559
19.

Plasma testosterone and prognosis of postmenopausal breast cancer patients.

Micheli A, Meneghini E, Secreto G, Berrino F, Venturelli E, Cavalleri A, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Veronesi U, Formelli F.

J Clin Oncol. 2007 Jul 1;25(19):2685-90. Epub 2007 Jun 4.

PMID:
17548841
20.

Radiation effects on development of HER2-positive breast carcinomas.

Castiglioni F, Terenziani M, Carcangiu ML, Miliano R, Aiello P, Bertola L, Triulzi T, Gasparini P, Camerini T, Sozzi G, Fossati-Bellani F, Ménard S, Tagliabue E.

Clin Cancer Res. 2007 Jan 1;13(1):46-51.

21.

Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis.

Mazzaferro V, Romito R, Schiavo M, Mariani L, Camerini T, Bhoori S, Capussotti L, Calise F, Pellicci R, Belli G, Tagger A, Colombo M, Bonino F, Majno P, Llovet JM; HCC Italian Task Force.

Hepatology. 2006 Dec;44(6):1543-54.

PMID:
17133492
22.

Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.

Cascinelli N, Bombardieri E, Bufalino R, Camerini T, Carbone A, Clemente C, Lenisa L, Mascheroni L, Maurichi A, Pennacchioli E, Patuzzo R, Santinami M, Tragni G.

J Clin Oncol. 2006 Sep 20;24(27):4464-71.

PMID:
16983115
23.

Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer.

Veronesi U, Mariani L, Decensi A, Formelli F, Camerini T, Miceli R, Di Mauro MG, Costa A, Marubini E, Sporn MB, De Palo G.

Ann Oncol. 2006 Jul;17(7):1065-71. Epub 2006 May 4.

PMID:
16675486
24.

Proposal of a novel system for the staging of thymic epithelial tumors.

Bedini AV, Andreani SM, Tavecchio L, Fabbri A, Giardini R, Camerini T, Bufalino R, Morabito A, Rosai J.

Ann Thorac Surg. 2005 Dec;80(6):1994-2000.

PMID:
16305831
25.

Study of sunbathing in children: the preliminary evaluation of a prevention program.

Manganoni AM, Cainelli T, Zumiani G, Bufalino R, Calzavara-Pinton P, Camerini T, Tucci G, Baldi M, Venturini M, Marini G, Cascinelli N.

Tumori. 2005 Mar-Apr;91(2):116-20.

PMID:
15948536
26.

Pigmented spindle-cell nevus: a melanoma simulator.

Maurichi A, Baldi M, Bartoli C, Bono A, Camerini T, Moglia D, Patuzzo R, Pennacchioli E, Tragni G, Santinami M.

Dermatol Online J. 2004 Oct 15;10(2):5. No abstract available.

PMID:
15530295
27.

Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study.

Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, Sarli D, Schiavo M, Garbagnati F, Marchianò A, Spreafico C, Camerini T, Mariani L, Miceli R, Andreola S.

Ann Surg. 2004 Nov;240(5):900-9.

28.

Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.

Decensi A, Veronesi U, Miceli R, Johansson H, Mariani L, Camerini T, Di Mauro MG, Cavadini E, De Palo G, Costa A, Perloff M, Malone WF, Formelli F.

Clin Cancer Res. 2003 Oct 15;9(13):4722-9.

29.

Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer.

Mazzaferro V, Coppa J, Carrabba MG, Rivoltini L, Schiavo M, Regalia E, Mariani L, Camerini T, Marchianò A, Andreola S, Camerini R, Corsi M, Lewis JJ, Srivastava PK, Parmiani G.

Clin Cancer Res. 2003 Aug 15;9(9):3235-45.

30.

Fenretinide breast cancer prevention trial: drug and retinol plasma levels in relation to age and disease outcome.

Formelli F, Camerini T, Cavadini E, Appierto V, Villani MG, Costa A, De Palo G, Di Mauro MG, Veronesi U.

Cancer Epidemiol Biomarkers Prev. 2003 Jan;12(1):34-41.

31.

Effect of fenretinide on ovarian carcinoma occurrence.

De Palo G, Mariani L, Camerini T, Marubini E, Formelli F, Pasini B, Decensi A, Veronesi U.

Gynecol Oncol. 2002 Jul;86(1):24-7.

PMID:
12079295
32.

Clinical and dermatoscopic diagnosis of early amelanotic melanoma.

Bono A, Maurichi A, Moglia D, Camerini T, Tragni G, Lualdi M, Bartoli C.

Melanoma Res. 2001 Oct;11(5):491-4.

PMID:
11595886
33.

Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer.

Decensi A, Johansson H, Miceli R, Mariani L, Camerini T, Cavadini E, Di Mauro MG, Barreca A, Gonzaga AG, Diani S, Sandri MT, De Palo G, Formelli F.

Cancer Epidemiol Biomarkers Prev. 2001 Oct;10(10):1047-53.

34.

Chemoprevention of breast cancer with fenretinide.

Torrisi R, Decensi A, Formelli F, Camerini T, De Palo G.

Drugs. 2001;61(7):909-18. Review.

PMID:
11434448
35.

Safety of the synthetic retinoid fenretinide: long-term results from a controlled clinical trial for the prevention of contralateral breast cancer.

Camerini T, Mariani L, De Palo G, Marubini E, Di Mauro MG, Decensi A, Costa A, Veronesi U.

J Clin Oncol. 2001 Mar 15;19(6):1664-70.

PMID:
11250995
36.

Re: Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

Ménard S, Camerini T, Mariani L, Tomasic G, Pilotti S, Costa A, De Palo G, Veronesi U.

J Natl Cancer Inst. 2001 Feb 7;93(3):240-1. No abstract available.

PMID:
11158198
37.

Small melanomas: a clinical study on 270 consecutive cases of cutaneous melanoma.

Bono A, Bartoli C, Moglia D, Maurichi A, Camerini T, Grassi G, Tragni G, Cascinelli N.

Melanoma Res. 1999 Dec;9(6):583-6.

PMID:
10661769
38.

Accrual issues for chemoprevention trials: the example of the 4-HPR study for the prevention of contralateral breast cancer.

Camerini T, De Palo G, Mariani L, Marubini E, Costa A, Veronesi U.

Tumori. 1999 Jul-Aug;85(4):299-303.

PMID:
10587038
39.

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

Veronesi U, De Palo G, Marubini E, Costa A, Formelli F, Mariani L, Decensi A, Camerini T, Del Turco MR, Di Mauro MG, Muraca MG, Del Vecchio M, Pinto C, D'Aiuto G, Boni C, Campa T, Magni A, Miceli R, Perloff M, Malone WF, Sporn MB.

J Natl Cancer Inst. 1999 Nov 3;91(21):1847-56.

PMID:
10547391
40.

Chemoprevention trial of contralateral breast cancer with fenretinide. Rationale, design, methodology, organization, data management, statistics and accrual.

De Palo G, Camerini T, Marubini E, Costa A, Formelli F, Del Vecchio M, Mariani L, Miceli R, Mascotti G, Magni A, Campa T, Di Mauro MG, Attili A, Maltoni C, Del Turco MR, Decensi A, D'Aiuto G, Veronesi U.

Tumori. 1997 Nov-Dec;83(6):884-94.

PMID:
9526578
41.

Chemoprevention of breast cancer with fenretinide (4-HPR): study of long-term visual and ophthalmologic tolerability.

Mariani L, Formelli F, De Palo G, Manzari A, Camerini T, Campa T, Di Mauro MG, Crippa A, Delle Grottaglie M, Del Vecchio M, Marubini E, Costa A, Veronesi U.

Tumori. 1996 Sep-Oct;82(5):444-9.

PMID:
9063520
42.

Retinoids in cancer chemoprevention. Clinical trials with the synthetic analogue fenretinide.

Costa A, De Palo G, Decensi A, Formelli F, Chiesa F, Nava M, Camerini T, Marubini E, Veronesi U.

Ann N Y Acad Sci. 1995 Sep 30;768:148-62. Review. No abstract available.

PMID:
8526344
43.

Can fenretinide protect women against ovarian cancer?

De Palo G, Veronesi U, Camerini T, Formelli F, Mascotti G, Boni C, Fosser V, Del Vecchio M, Campa T, Costa A, et al.

J Natl Cancer Inst. 1995 Jan 18;87(2):146-7. No abstract available.

PMID:
7707390
44.

Controlled clinical trials with fenretinide in breast cancer, basal cell carcinoma and oral leukoplakia.

De Palo G, Veronesi U, Marubini E, Camerini T, Chiesa F, Nava M, Formelli F, Del Vecchio M, Costa A, Boracchi P, et al.

J Cell Biochem Suppl. 1995;22:11-7. Review.

PMID:
8538187
45.

Behavior of some steroids in endometrial adenomatous and atypical hyperplasia.

Pelusi G, Moretti B, Martinelli G, Camerini T, Busacchi P, Cavallina R.

Eur J Gynaecol Oncol. 1983;4(2):131-4.

PMID:
6223817

Supplemental Content

Loading ...
Support Center